Traumatic Brain Injury Diagnostics Equipment Market Growth - 2030

Traumatic Brain Injury Diagnostics Equipment Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Noninvasive, Invasive, and Combination Techniques), Device Type (Imaging Devices and Monitoring Devices), End User (Hospitals & Clinics, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Publication Month : Feb 2024

  • Report Code : TIPRE00018814
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 305
Inquire Before Buy

PRICING

$5190

$4152

[Research Report] The traumatic brain injury diagnostics equipment market is projected to grow from US$ 3.157 billion in 2022 to US$ 7.872 billion by 2030; the market is estimated to record a CAGR of 12.1% during 2022–2030.

Market Insights and Analyst View:

Factors such as the accelerated demand for advanced diagnostic equipment and quick and effective diagnosis for TBI patients propel the traumatic brain injury diagnostics equipment market growth. However, the adverse effects of contrast medium/agent impede the growth of the market.

Growth Drivers:

Accelerated Demand for Advanced Diagnostic Equipment Drives Traumatic Brain Injury Diagnostics Equipment Market Growth

According to the Medical Research Council 2022 report, 10 million people across the world sustain traumatic brain injury (TBI) annually. Likewise, the Headway 2024 report revealed that acquired brain injury (ABI) is rising in the UK; a total of 356,699 hospital admissions were registered due to ABI in the UK from 2019 to 2020. Among these, the male population was 1.5 times higher than females admitted to hospitals for a head injury. As per The Economist Intelligence Unit report, the global healthcare burden of TBI is estimated to be around US$ 400 billion annually. The most common form of ABI is TBI due to an accident or stroke. The Centers for Disease Control and Prevention (CDC) report revealed that an estimated 1.7 million TBI-related emergency department visits, hospitalizations, and deaths occur annually in the US, especially among adults aged 75 years and older as they are at high risk of falling due to problems with gait and balance. Also, road accidents are the leading cause of TBI-related deaths in the US and are highest among adults aged 20–24 years. Therefore, manufacturers are developing innovative products to diagnose TBI. In October 2023, bioMérieux announced Conformité Européenne (CE) marking for "VIDAS TBI (GFAP, UCH-L1)," a test intended to improve the assessment of patients suffering from mild traumatic brain injury (mTBI). VIDAS TBI (GFAP, UCH-L1) test measures the concentration of glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1)—the two brain biomarkers released into the bloodstream starting from the first hour following a brain injury. It is an easy-to-interpret test providing a test window of up to 12 hours after injury, which can help in shortening total emergency department workup time. The product's commercial launch was in 2023 for selected European, North African, and South American markets; the global launch is planned for 2024 or 2025.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Traumatic Brain Injury Diagnostics Equipment Market: Strategic Insights

traumatic-brain-injury-diagnostic-equipment-market
Market Size Value inUS$ 3.157 billion in 2022
Market Size Value byUS$ 7.872 billion by 2030
Growth rateCAGR of 12.1% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The “traumatic brain injury diagnostics equipment market analysis” is drawn by considering the following segments: technique, device type, and end user.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

By technique, the traumatic brain injury diagnostics equipment market is segmented into noninvasive, invasive, and combination techniques. The invasive segment held the largest market share in 2022. The non-invasive segment is anticipated to register the highest CAGR of 12.8% during the forecast period.

Noninvasive ultrasound technology is used to efficiently screen the severity of traumatic brain injury (TBI). The EU-funded project "BRAINSAFE" introduced an easy-to-use, handheld, noninvasive absolute intracranial pressure (aICP) meter. This device is an effective alternative to painful, invasive procedures used to assess intracranial injuries. The aICP meter utilizes Doppler ultrasound technology to evaluate blood flow parameters in the ophthalmic artery with the help of a disposable pressure cuff and head frame.

Traumatic Brain Injury Diagnostics Equipment Market Share, by Technique – 2022 and 2030

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

The traumatic brain injury diagnostics equipment market, by device type, is bifurcated into imaging devices and monitoring devices. The imaging devices segment held a larger market share in 2022 and is anticipated to register a considerable CAGR of 11.8% during the forecast period.

The traumatic brain injury diagnostics equipment market, by end user, is categorized into hospitals & clinics, diagnostic centers, and others. The hospitals & clinics segment held the largest market share in 2022 and is anticipated to register a CAGR of 12.0% during the forecast period.

Emergence of Portable Nonivasive Monitoring Devices to Diagnose TBI Patients Acts as a Future Trend in Traumatic Brain Injury Diagnostics Equipment Market

New noninvasive methods for monitoring tissue metabolism can help improve the diagnosis and monitoring of brain conditions such as concussions, stroke, and TBI, owing to which patients can recover more quickly. The consequences of TBI resulted in increasing healthcare burden costs, accounting for US$ 76.5 billion annually, as per the BrainScope company white paper. The installation of "BrainScope One" in less expensive care settings—e.g., emergency department and community settings (including urgent care centers)—may result in a significant reduction of healthcare costs by up to 32.2%, as per the findings revealed in the white paper. BrainScope One aids in eliminating unnecessary CT scans, thereby reducing healthcare costs for TBI.

Further, a team of researchers from the University of Michigan developed a cost-effective, portable, noninvasive tool—Super-Continuum Infrared Spectroscopy of Cytochrome C-Oxidase (SCISCCO) system—to detect neuronal dysfunction. This tool is extremely versatile, having a range of uses from serving as a new device for screening concussion patients to use in the intensive care unit and gauging patients' organ response to treatment.

Likewise, the University of Birmingham 2024 report revealed that researchers from the University of Birmingham have designed and developed the eye-safe device (EyeD)—a novel diagnostic device to detect TBI. It is based on Raman spectroscopy, an optical technique performed simultaneously on fundus imaging and spectroscopic analysis using a smartphone camera. The Raman spectra collected by EyeD from the retina and optic nerves help in analyzing the presence of TBI-specific biochemical changes using the artificial neural network algorithm "SKiNET" as a decision support tool. EyeD is quick, accurate, and noninvasive, causes no additional discomfort, and provides information on the severity of the trauma instantly, owing to which it is highly suitable while using on-site—at the roadside of the unfortunate event or on the sports pitch—to assess TBI.

Regional Analysis:

The scope of the global traumatic brain injury diagnostics equipment market report entails North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest traumatic brain injury diagnostics equipment market share. The US is the largest contributor to the market in North America. The Centers for Disease Control and Prevention (CDC) report revealed that an estimated 2.5 million people suffer from TBI annually in the US. According to the KNAPP & ROBERTS report, 1 in every 6 Americans live with TBI-related disability in the US alone, accounting for approx. 5.3 million. With the rising prevalence of TBI, the economic cost accounts for US$ 76.5 billion. Among US$ 76.5 billion, US$ 11.5 billion accounts for direct medical costs and nearly US$ 65 billion for indirect costs. The leading causes of TBI include falls (45%), motor vehicle crashes (14.3%), assaults (10.7%), and unknown (19.0%).

Further, companies are launching innovative products for the diagnosis of TBI. For instance, in August 2022, Abbott announced a new blood test for concussions to predict outcomes from brain injury and treatment interventions. The researchers used Abbott's "i-STAT TBI Plasma Test," the only FDA-cleared rapid test intended for concussion, and Abbott's core laboratory ARCHITECT instrument to measure two biomarkers in blood plasma associated with brain injury. The i-STAT TBI Plasma test measures the level of biomarkers released in the bloodstream in response to the brain injury; the level of biomarkers assists in determining the need for a CT scan.

Additionally, Sense Neuro Diagnostics announced clearance to conduct clinical trials for hemorrhage detection. The new trial approved by the FDA Division of Neurosurgical, Neurointerventional, and Neurodiagnostic Devices began in June 2023, including up to 300 patients at 30 US, Canada, and Indian sites. This noninvasive technology has the potential to collect 360 data points within 2.5 seconds to detect brain hemorrhage or stroke type, thereby helping quick response by physicians, emergency department personnels, neuro ICU teams, and military field hospitals assessing and monitoring TBI. Therefore, the traumatic brain injury diagnostics equipment market size is likely to surge due to innovative product launches by US-based companies to improve outcomes of diagnosis of patients suffering from TBI.

Industry Developments and Future Opportunities:

The traumatic brain injury diagnostics equipment market forecast can help stakeholders in this marketplace plan their growth strategies. A few strategic developments by leading players operating in the market are listed below:

  • In October 2023, GE Healthcare Technologies Inc announced a collaboration with Imeka to expand the capabilities of MRI for brain imaging and further develop advanced precision medicine for brain health. Under the collaboration, GE Healthcare Technologies Inc has utilized Imeka’s neuroimaging technology, ANIE biomarker platform, which has broader applicabilities in research and clinical care settings across the spectrum of central nervous system diseases and disorders, such as traumatic brain injury, Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. The ANIE biomarker platform is integrated with artificial intelligence that identifies and quantifies axonal loss, neuroinflammation, and demyelination. Thus, with the collaboration, GE Healthcare Technologies Inc integrated its BrainWave advanced diffusion processing package with the ANIE biomarker platform. The newly integrated technologies have allowed researchers and clinicians to analyze diffusion MRI signals in the brain in greater detail.

Competitive Landscape and Key Companies:

Besides highlighting the factors impacting the market, the traumatic brain injury diagnostics equipment market report showcases the developments of prominent players. GE HealthCare Technologies Inc, Elekta AB, Integra LifeSciences Holdings Corp, Natus Medical Inc, Raumedic AG, BrainScope Co Inc, Luciole Medical AG, Soterix Medical Inc, Medtronic Plc, Vivonics Inc, NanoDx Inc, Compumedics Ltd, Sense Diagnostics Inc, NeuraSignal Inc, and Neurovigil Inc are among the prominent companies operating in the market. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Technique, Device Type, End User, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the Traumatic Brain Injury Diagnostic Equipment?

The traumatic brain injury diagnostic equipment majorly consists of the players such GE HealthCare Technologies Inc, Elekta AB, Integra LifeSciences Holdings Corp, Natus Medical Inc, Raumedic AG, BrainScope Co Inc, Luciole Medical AG, Soterix Medical Inc, Medtronic Plc, Vivonics Inc, NanoDx Inc, Compumedics Ltd, Sense Diagnostics Inc, NeuraSignal Inc, and Neurovigil Inc, and among others.

What are the driving factors for the Traumatic Brain Injury Diagnostic Equipment across the globe?

Key factors that are driving the growth of this market are accelerated demand for advanced diagnostic equipment and quick and effective diagnosis for TBI patients.

What is the market CAGR value of Traumatic Brain Injury Diagnostic Equipment during forecast period?

The CAGR value of the traumatic brain injury diagnostic equipment during the forecasted period of 2022-2030 is 12.1%.

Which device type held the largest share in the Traumatic Brain Injury Diagnostic Equipment?

The imaging device segment dominated the traumatic brain injury diagnostic equipment and held the largest market share in 2022.

What is Traumatic Brain Injury Diagnostic Equipment?

A TBI may be open (penetrating) or closed (non-penetrating). A penetrating TBI occurs when a physical, external forces affect the brain and an object enters the brain tissue. A closed TBI is caused by an external force that produces movement of the brain without skull. Therefore, rising prevalence of TBI increases diagnosis process by the clinicians to assess the severity of TBI.

The List of Companies - Traumatic Brain Injury Diagnostic Equipment Market

  • GE HealthCare Technologies Inc
  • Elekta AB
  • Integra LifeSciences Holdings Corp
  • Natus Medical Inc
  • Raumedic AG
  • BrainScope Co Inc
  • Luciole Medical AG
  • Soterix Medical Inc
  • Medtronic Plc
  • Vivonics Inc
  • NanoDx Inc
  • Compumedics Ltd
  • Sense Diagnostics Inc
  • NeuraSignal Inc
  • Neurovigil Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Traumatic Brain Injury Diagnostics Equipment Market